Update on Mounjaro 05/08/25 Posted or Updated on 5 Aug 2025

What’s New?

The NHS has introduced new prescribing criteria for Mounjaro (tirzepatide) in General Practice. These changes are part of a phased rollout and aim to ensure the treatment is provided to those who are most likely to benefit.

Who Can Be Prescribed Mounjaro?

At this stage, Mounjaro will only be offered to adults who meet all of the following criteria:

• Body Mass Index (BMI) of 40 or above

• Diagnosed with at least four of the following five conditions:

  • Type 2 Diabetes

  • High blood pressure (Hypertension)

  • Abnormal cholesterol levels (Dyslipidaemia)

  • Cardiovascular disease

  • Obstructive sleep apnoea

Who Should Not Take Mounjaro?

Mounjaro is not suitable for the following individuals:

• Under 18 years of age

• Pregnant or breastfeeding

• Personal or family history of medullary thyroid cancer (MTC)

• Diagnosis of Multiple Endocrine Neoplasia Syndrome Type 2 (MEN2)

• Known allergy to tirzepatide or any of its ingredients

What You Need to Do

If you believe you meet the eligibility criteria:

• We must have a recent BMI measurement (within the last 3 months) on your medical record.

• If your BMI has not been recorded recently, please book an appointment with our Healthcare Assistant for a height and weight check.

• If your BMI is 40 or above, we will discuss the next steps with you.

• Please do not stop any existing medications unless advised by a clinician.

What If Your BMI Is Below 40?

If your BMI is currently under 40, you will not be eligible for Mounjaro through the NHS at this time. However, we can still help. Our team can offer support and refer you to local weight management services tailored to your needs.

If you have any questions or need further advice, please contact the surgery.